INCY

Incyte Genomics Inc

106.67

USD

INCY Earnings Reports

Positive Surprise Ratio

INCY beat 20 of 39 last estimates.

51%

Next Report

Date of Next Report

Feb 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

$1.38B

$1.95

Implied change from Q3 25 (Revenue/ EPS)

+0.81%

-13.33%

Implied change from Q4 24 (Revenue/ EPS)

+16.83%

+36.36%

Incyte Genomics Inc earnings per share and revenue

On Oct 28, 2025, INCY reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 1.68 USD, resulting in a 33.74% surprise. Revenue reached 1.37 billion, compared to an expected 1.28 billion, with a 6.70% difference. The market reacted with a -1.54% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 25 analysts forecast an EPS of 1.95 USD, with revenue projected to reach 1.38 billion USD, implying an decrease of -13.33% EPS, and increase of 0.81% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Citius Oncology, Inc. Common Stock

Report Date

Dec 23, 2025 For Q4 25

Estimate

-$0.12

Actual

-$0.06

Surprise

+50.98%

FAQ

What were Incyte Genomics Inc's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Incyte Genomics Inc reported EPS of $2.25, beating estimates by 33.74%, and revenue of $1.37B, 6.7% above expectations.

How did the market react to Incyte Genomics Inc's Q3 2025 earnings?

The stock price moved down -1.54%, changed from $93.08 before the earnings release to $91.65 the day after.

When is Incyte Genomics Inc expected to report next?

The next earning report is scheduled for Feb 09, 2026.

What are the forecasts for Incyte Genomics Inc's next earnings report?

Based on 25 analysts, Incyte Genomics Inc is expected to report EPS of $1.95 and revenue of $1.38B for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.